| Authors: |
Rubins DJ; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA. Daniel_rubins@merck.com., Meng X; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., McQuade P; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Klimas M; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Getty K; Screening and Protein Sciences Department, Merck & Co., Inc., West Point, PA, USA., Lin SA; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Connolly BM; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., O'Malley SS; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Haley H; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Purcell M; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Gantert L; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Holahan M; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Lindgren J; Affibody AB, Solna, Sweden., Eklund P; Affibody AB, Solna, Sweden., Ekblad C; Affibody AB, Solna, Sweden., Frejd FY; Affibody AB, Solna, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Hostetler ED; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., González Trotter DE; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA., Evelhoch JL; Translational Biomarkers Department, Merck & Co., Inc., West Point, PA, USA. |
